The Role of Artificial Intelligence in Clinical Trial Design and Research with Dr. ElZarrad

Real-World Data and Evidence Generation with Dr. Hilary Marston

REdI 2024 | D1S06 - Responsive Regulation of Artificial Intelligence in Drug Development

FDA Clinical Investigator Training Course (CITC) 2024 – Day One – Session One

Medical Device Quality Management System Regulation Risk Management

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S07 – Q&A Discussion Panel

GCP & Pharmacovigilance Compliance Symposium | D3S03-1 - (BE): Clinical Study Conduct

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S05 - (PV): Future of...

Medical Device Quality Management System Regulation Design and Development

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S03-2 – Q&A Discussion Panel

Initiating the Removal of the “Black Box Warning” on Hormone Replacement Therapy

Recognizing and Reporting Potentially False or Misleading Prescription Drug Promotion with Dr. Ca...

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S06 - (PV): Regulatory Updates

Conversations on Cancer – Perspectives on Cancer Care Decision-Making Among Older Adults

GCP & Pharmacovigilance Compliance Symposium | D2S06 – Panel Discussion

FDA Direct with Dr. Martin Makary, FDA Commissioner

FDA Direct: An Eye on CDRH: Regulating for a New Era of Medical Devices

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S08 – Symposium Wrap-up and...

FDA Expert Panel on Testosterone Replacement Therapy for Men

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S04 - (PV): International...

Public Meeting: Reauthorization of the Biosimilar User Fee Act